Pipeline

CavoGene Pipeline

CavoGene’s Competitive Advantage

  • Gene expression platform for multiple CNS and neurodegenerative diseases
  • Validated animal data lead to long term diversified risk
  • Transition from research to IND-enabling studies for rapid commercialization
  • Emphasis on protecting intellectual property and shareholder value
  • Significant potential for non-dilutive financing and partnering activities
  • Strategic financing, exit and liquidity options Multiple strategic partnerships
  • Exclusive license from UCSD
  • 2 issued patents with extensive claims & FTO
  • Non-Provisional PCT (2020 actionable date) 
  • Gavrilovich, Dodd & Lindsey LLP (IP counsel)
  • Tucker Ellis, LLP (Corporate counsel)
colorful of CT angiography of the brain or CTA brain  Sagittal view . Clipping path.